Patients with severe COVID-19 are characterized by local and systemic inflammatory responses, which are responsible for severe acute respiratory failure. Systemic corticosteroids have been used to counteract the inflammatory cascade in severe respiratory patients. The beneficial effect of corticosteroids may be counteracted by adverse effects, including delayed viral clearance and increased risk of secondary infection. In this regard, we describe a case of a 79-year-old man admitted to the Emergency Department of the Palermo Hospital (Italy) because of respiratory failure and pneumonia caused by SARS-CoV-2 infection who developed Nocardia otitidiscaviarum infection. This case highlights the need to consider coinfections in SARS-CoV-2 patients under high dose of steroids.

Maria N. CICERO, A.I.M. (2022). A 79-year-old-man with SARS-CoV-2 pneumonia and unusual pulmonary co-infection. MINERVA RESPIRATORY MEDICINE [10.23736/S2784-8477.21.01993-8].

A 79-year-old-man with SARS-CoV-2 pneumonia and unusual pulmonary co-infection

Maria N. CICERO
Primo
;
Anna I. MEMMO;Ilaria R. PICCIONELLO;Gabriele SEMINARA;Alida BENFANTE;Nicola SCICHILONE
Ultimo
2022-06-01

Abstract

Patients with severe COVID-19 are characterized by local and systemic inflammatory responses, which are responsible for severe acute respiratory failure. Systemic corticosteroids have been used to counteract the inflammatory cascade in severe respiratory patients. The beneficial effect of corticosteroids may be counteracted by adverse effects, including delayed viral clearance and increased risk of secondary infection. In this regard, we describe a case of a 79-year-old man admitted to the Emergency Department of the Palermo Hospital (Italy) because of respiratory failure and pneumonia caused by SARS-CoV-2 infection who developed Nocardia otitidiscaviarum infection. This case highlights the need to consider coinfections in SARS-CoV-2 patients under high dose of steroids.
Maria N. CICERO, A.I.M. (2022). A 79-year-old-man with SARS-CoV-2 pneumonia and unusual pulmonary co-infection. MINERVA RESPIRATORY MEDICINE [10.23736/S2784-8477.21.01993-8].
File in questo prodotto:
File Dimensione Formato  
CIcero_Minerva Pneumologica_21.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 859.43 kB
Formato Adobe PDF
859.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/578512
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact